Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Pemphigus and Pemphigoid

References

• Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J Allergy Clin Immunol. 2020;145(4):1031–1047. doi:10.1016/j.jaci.2020.02.013.
   PubMed Web of Science ®Google Scholar
• Witte M, Zillikens D, Schmidt E. Diagnosis of autoimmune blistering diseases. Front Med. 2018;5:296. doi:10.3389/fmed.2018.00296.
   PubMed Web of Science ®Google Scholar
• Feizi S, Roshandel D. Ocular manifestations and management of autoimmune bullous diseases. J Ophthalmic Vis Res. 2019;14(2):195–210. doi:10.4103/jovr.jovr_86_18.
   PubMed Web of Science ®Google Scholar
• Zhao CY, Murrell DF. Outcome measures for autoimmune blistering diseases. J Dermatol. 2015;42(1):31–36. doi:10.1111/1346-8138.12711.
   PubMed Web of Science ®Google Scholar
• Broussard KC, Leung TG, Moradi A, Thorne JE, Fine JD. Autoimmune bullous diseases with skin and eye involvement: cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica. Clin Dermatol. 2016;34(2):205–213. doi:10.1016/j.clindermatol.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Memar O, Jabbehdari S, Caughlin B, Djalilian AR. Ocular surface involvement in pemphigus vulgaris: an interdisciplinary review. Ocul Surf. 2020;18(1):40–46. doi:10.1016/j.jtos.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Dart J. Cicatricial pemphigoid and dry eye. Semin Ophthalmol. 2005;20(2):95–100. doi:10.1080/08820530590931368.
   PubMedGoogle Scholar
• Chirinos-Saldaña P, Navas A, Ramírez-Miranda A, Jiménez-Martínez MC, Graue-Hernández EO. Pemphigus: an ophthalmological review. Eye Contact Lens. 2016;42(2):91–98. doi:10.1097/icl.0000000000000155.
   PubMed Web of Science ®Google Scholar
• Cao T, Shao S, Fang H, Li B, Wang G. Role of regulatory immune cells and molecules in autoimmune bullous dermatoses. Front Immunol. 2019;10:1746. doi:10.3389/fimmu.2019.01746.
   PubMed Web of Science ®Google Scholar
• Edwards G, Diercks GFH, Seelen MAJ, Horvath B, van Doorn MBA, Damman J. Complement activation in autoimmune bullous dermatoses: a comprehensive review. Front Immunol. 2019;10:1477. doi:10.3389/fimmu.2019.01477.
   PubMed Web of Science ®Google Scholar
• Ellebrecht CT, Maseda D, Payne AS. Pemphigus and pemphigoid: from disease mechanisms to druggable pathways. J Invest Dermatol. 2022;142(3 Pt B):907–914. doi:10.1016/j.jid.2021.04.040.
   PubMed Web of Science ®Google Scholar
• Hohenstein-Blaul NVU, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res. 2013;117:126–137. doi:10.1016/j.exer.2013.07.015.
   PubMed Web of Science ®Google Scholar
• Bruscolini A, Lambiase A, Segatto M, La Cava M, Nebbioso M, Sacchetti M. Evaluation of IL8 pathway on the ocular surface: new insights in patients with ocular mucous membrane pemphigoid. Acta Ophthalmol. 2020;98(2):e173–e7. doi:10.1111/aos.14240.
   PubMed Web of Science ®Google Scholar
• Arafat SN, Suelves AM, Spurr-Michaud S, et al. Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology. 2014;121(1):79–87. doi:10.1016/j.ophtha.2013.06.049.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Rolando M, Benitez Del Castillo JM, et al. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog Retin Eye Res. 2019;71:68–87. doi:10.1016/j.preteyeres.2018.11.007.
   PubMed Web of Science ®Google Scholar
• Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol. 1984;102(7):1049–1051. doi:10.1001/archopht.1984.01040030851031.
   PubMedGoogle Scholar
• Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch Ophthalmol. 1983;101(8):1284–1287. doi:10.1001/archopht.1983.01040020286025.
   PubMedGoogle Scholar
• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006–2049. doi:10.1167/iovs.10-6997f.
   PubMed Web of Science ®Google Scholar
• Pult H, Bandlitz S. Lid-parallel conjunctival folds and their ability to predict dry eye. Eye Contact Lens. 2018;44(Suppl 2):S113–S9. doi:10.1097/ICL.0000000000000435.
   PubMedGoogle Scholar
• The international dry eye workshop. Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye workShop (2007). Ocul Surf. 2007;5(2):108–152. doi:10.1016/s1542-0124(12)70083-6.
   PubMed Web of Science ®Google Scholar
• Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008.
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Ma B, Zhou Y, Liu R, et al. Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf. 2021;20:70–85. doi:10.1016/j.jtos.2020.12.007.
   PubMed Web of Science ®Google Scholar
• Nelson JD. Impression cytology. Cornea. 1988;7(1):71–81. doi:10.1097/00003226-198801000-00012.
   PubMed Web of Science ®Google Scholar
• Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol. 2016;11:175–197. doi:10.1146/annurev-pathol-012615-044313.
   PubMed Web of Science ®Google Scholar
• Wang K, Seitzman G, Gonzales JA. Ocular cicatricial pemphigoid. Curr Opin Ophthalmol. 2018;29(6):543–551. doi:10.1097/ICU.0000000000000517.
   PubMed Web of Science ®Google Scholar
• Hong GH, Khan IR, Shifera AS, Okeagu C, Thorne JE. Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid. Ocul Immunol Inflamm. 2019;27(5):821–825. doi:10.1080/09273948.2018.1455879.
   PubMed Web of Science ®Google Scholar
• Queisi MM, Zein M, Lamba N, Meese H, Foster CS. Update on ocular cicatricial pemphigoid and emerging treatments. Surv Ophthalmol. 2016;61(3):314–317. doi:10.1016/j.survophthal.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Branisteanu DC, Stoleriu G, Branisteanu DE, et al. Ocular cicatricial pemphigoid (Review). Exp Ther Med. 2020;20(4):3379–3382. doi:10.3892/etm.2020.8972.
   PubMed Web of Science ®Google Scholar
• Akhyani M, Keshtkar-Jafari A, Chams-Davatchi C, et al. Ocular involvement in pemphigus vulgaris. J Dermatol. 2014;41(7):618–621. doi:10.1111/1346-8138.12447.
   PubMed Web of Science ®Google Scholar
• Chirinos-Saldaña P, Zuñiga-Gonzalez I, Hernandez-Camarena JC, et al. Cicatricial changes in ocular pemphigus. Eye. 2014;28(4):459–465. doi:10.1038/eye.2014.3.
   PubMed Web of Science ®Google Scholar
• Kanwar AJ, Vinay K, Sawatkar GU, et al. Clinical and immunological study of mucous membrane pemphigoid in a cohort of Indian patients. Int J Dermatol. 2016;55(10):e557–61. doi:10.1111/ijd.13339.
   PubMed Web of Science ®Google Scholar
• Morel M, DeGrazia T, Ward L, Behshad S, Kim HJ, Feldman R. Single center retrospective study of patients with ocular mucous membrane pemphigoid (MMP). Ocul Immunol Inflamm. 2020;1–6. doi:10.1080/09273948.2020.1783322.
   Web of Science ®Google Scholar
• Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2010;51(4):1994–2002. doi:10.1167/iovs.09-4130.
   PubMed Web of Science ®Google Scholar
• Marmalidou A, Kheirkhah A, Dana R. Conjunctivochalasis: a systematic review. Surv Ophthalmol. 2018;63(4):554–564. doi:10.1016/j.survophthal.2017.10.010.
   PubMed Web of Science ®Google Scholar
• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Iuliano L, Berchicci L, Bandello F, Modorati G. Tear film osmolarity in ocular mucous membrane pemphigoid. Cornea. 2014;33(7):668–672. doi:10.1097/ICO.0000000000000148.
   PubMed Web of Science ®Google Scholar
• Bobba S, Devlin C, Di Girolamo N, et al. Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand. Eye. 2018;32(10):1636–1643. doi:10.1038/s41433-018-0155-7.
   PubMed Web of Science ®Google Scholar
• Kiyat P, Palamar M, Gerceker Turk B, Yagci A. Dry eye and quantitative and qualitative changes of meibomian glands in patients with pemphigus. Cornea. 2020;39(9):1108–1111. doi:10.1097/ico.0000000000002356.
   PubMed Web of Science ®Google Scholar
• Tan JC, Tat LT, Francis KB, Mendoza CG, Murrell DF, Coroneo MT. Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndrome. Cornea. 2015;34(4):443–448. doi:10.1097/ico.0000000000000335.
   PubMed Web of Science ®Google Scholar
• Mizoguchi S, Iwanishi H, Arita R, et al. Ocular surface inflammation impairs structure and function of meibomian gland. Exp Eye Res. 2017;163:78–84. doi:10.1016/j.exer.2017.06.011.
   PubMed Web of Science ®Google Scholar
• Gipson IK. Goblet cells of the conjunctiva: a review of recent findings. Prog Retin Eye Res. 2016;54:49–63. doi:10.1016/j.preteyeres.2016.04.005.
   PubMed Web of Science ®Google Scholar
• Shamloo K, Barbarino A, Alfuraih S, Sharma A. Graft versus host disease-associated dry eye: role of ocular surface mucins and the effect of rebamipide, a mucin secretagogue. Invest Ophthalmol Vis Sci. 2019;60(14):4511–4519. doi:10.1167/iovs.19-27843.
   PubMed Web of Science ®Google Scholar
• Contreras-Ruiz L, Ghosh-Mitra A, Shatos MA, Dartt DA, Masli S. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm. 2013;2013:636812. doi:10.1155/2013/636812.
   PubMed Web of Science ®Google Scholar
• López-García JS, Rivas Jara L, García-Lozano CI, Conesa E, de Juan IE, Murube Del Castillo J. Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis. Ophthalmology. 2011;118(2):265–271. doi:10.1016/j.ophtha.2010.06.035.
   PubMed Web of Science ®Google Scholar
• Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. doi:10.3390/ijms20236008.
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12(1):49–62. doi:10.1038/nrrheum.2015.169.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8–27. doi:10.1111/imr.12621.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307(1):97–101. doi:10.1016/0014-5793(92)80909-z.
   PubMed Web of Science ®Google Scholar
• Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004;36(10):1882–1886. doi:10.1016/j.biocel.2003.10.019.
   PubMed Web of Science ®Google Scholar
• Suelves AM, Zhao TZ, Siddique SS, Foster CS. Profile of local interleukin expression in a cohort of ocular cicatricial pemphigoid patients. Invest Ophthalmol Vis Sci. 2012;53(13):8112–8117. doi:10.1167/iovs.11-9322.
   PubMed Web of Science ®Google Scholar
• Daoud YJ, Foster CS, Ahmed R. Eyelid skin involvement in pemphigus foliaceus. Ocul Immunol Inflamm. 2005;13(5):389–394. doi:10.1080/09273940590951025.
   PubMed Web of Science ®Google Scholar